New AI-generated COVID drug enters Phase I clinical trials: ‘Effective against all variants’

2 years ago 31

Insilico Medicine recently announced that its new AI-designed drug for COVID-19 has entered Phase I clinical trials. If approved, it would become the first-ever alternative to Paxlovid.

1. Homepage
2. National News
3. New AI-generated COVID drug enters Phase I clinical trials: ‘Effective against all variants’